Evolent Health Intrinsic Value – Analysts Give Evolent Health, a ‘Moderate Buy’ Consensus Rating
December 21, 2023
🌥️Trending News
Evolent Health ($NYSE:EVH), Inc. (EVH) has been given a “Moderate Buy” consensus rating by analysts. The company is a leading provider of population health and value-based care solutions for health systems, health plans, and employers, enabling them to improve the quality of care and reduce costs. Their offerings include a suite of data-driven services, software-enabled decision support, and partnerships with health care providers to manage care for complex patient populations. The company’s services are designed to help health plans, health systems, and employers control costs by improving the quality of care, engaging patients in their own care, and engaging providers in population health initiatives. Evolent Health has a long-term track record of success and offers a comprehensive platform that offers advanced analytics, data-driven services, and tailored solutions for health plans, health systems, and employers. The company’s analytics platform is designed to facilitate the delivery of care in a cost-effective manner and to provide insights that enable organizations to make decisions more quickly and accurately. The analytics platform also provides insight into patient population health trends, helping to guide the development of strategies for improved care management.
Additionally, Evolent Health’s value-based care solutions are designed to reduce costs and improve outcomes through provider collaboration and patient engagement. Analysts have rated Evolent Health as a “Moderate Buy” due to its strong performance in the population health and value-based care markets. The company has been able to establish itself as a leader in these areas and has continually developed innovative solutions that have helped to reduce costs while improving quality of care. As a result, analysts believe that the company is well positioned to continue its success in the future.
Stock Price
It opened at $30.1 and closed at $30.7, representing a 1.2% increase from its previous closing price of $30.3. This rating comes as a positive sign for investors looking to invest in the company, as it indicates the strong potential for growth in the near future. Analysts are confident that EVOLENT HEALTH‘s innovative health care technology and robust business model will enable the company to continue to deliver impressive returns for investors. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Evolent Health. More…
| Total Revenues | Net Income | Net Margin |
| 1.79k | -112.21 | -4.2% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Evolent Health. More…
| Operations | Investing | Financing |
| 88.9 | -413.95 | 354.84 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Evolent Health. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 2.67k | 1.57k | 9.53 |
Key Ratios Snapshot
Some of the financial key ratios for Evolent Health are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 22.0% | – | -6.5% |
| FCF Margin | ROE | ROA |
| 3.1% | -6.6% | -2.7% |
Analysis – Evolent Health Intrinsic Value
At GoodWhale, we analyzed EVOLENT HEALTH‘s financials and used our proprietary Valuation Line to calculate the intrinsic value of its share. Our analysis found that the intrinsic value of EVOLENT HEALTH share is around $33.8. This value is higher than the actual trading price of $30.7, indicating that EVOLENT HEALTH stock is currently undervalued by 9.2%. We believe this stock is a good buy for investors who are looking for long-term investments in healthcare companies. More…
Peers
The company’s products and services enable healthcare providers to receive and process payments from patients and third-party payers. Evolent Health Inc’s competitors include PreAxia Health Care Payment Systems Inc, Livecare Inc, PT Bundamedik Tbk, and other healthcare payment processing companies.
– PreAxia Health Care Payment Systems Inc ($OTCPK:PAXH)
PreAxia Health Care Payment Systems Inc is a healthcare technology company that provides solutions to healthcare organizations and payers. Its products and services include claims processing, payment processing, and data management. The company was founded in 1997 and is headquartered in Boston, Massachusetts.
– Livecare Inc ($OTCPK:LVCE)
The companyPT Bundamedik Tbk is a leading healthcare provider in Indonesia. The company has a market cap of 4.73T as of 2022 and a ROE of 10.69%. The company is focused on providing quality healthcare services to the Indonesian people. The company has a strong presence in the Indonesian healthcare market and is committed to providing the best possible care to its patients.
Summary
Evolent Health, Inc. (EVH) is a healthcare technology and services company with a focus on population health management. The company has a consensus rating of “Moderate Buy” from analysts. Investors are encouraged to view the company’s long-term prospects positively. EVH’s innovative technology platform, combined with a focus on providing cost-effective care, mean that it could be a successful investment. The company has seen positive revenue growth over the last few years, and is well-positioned to continue to drive value for its shareholders. It has an experienced management team and a strong network of strategic partners that allow it to remain competitive and capitalize on industry changes.
Additionally, EVH’s effective risk management helps protect it from potential losses. All in all, investors should consider EVH as an attractive long-term investment opportunity.
